IP Library Granted Patent US 11,572,549
Granted Patent B2
US 11,572,549 · App. 17/376,322 · Granted Feb 7, 2023

Engineered aryl sulfate-dependent enzymes

Inventor: Tarsis Gesteira Ferreira (Pearland, TX)
Assignee: OPTIMVIA, LLC
C12N9/13C12N15/63C12P19/64C12Y208/02008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,572,549
App. No.
17/376,322
Granted
Feb 7, 2023
Kind
B2
Abstract

The present invention provides several non-naturally occurring sulfotransferase enzymes that have been engineered to react with aryl sulfate compounds as sulfo group donors, instead of the natural substrate 3′-phosphoadenosine 5′-phosphosulfate (PAPS), and with heparosan-based polysaccharides, particularly heparan sulfate, as sulfo group acceptors. Each of the engineered sulfotransferase enzymes have a biological activity characterized by the position within the heparosan-based polysaccharide that receives the sulfo group, including glucosaminyl N-sulfotransferase activity, hexuronyl 2-O sulfotransferase activity, glucosaminyl 6-O sulfotransferase activity, or glucosaminyl 3-O sulfotransferase activity. Methods of using the engineered sulfotransferases to produce sulfated heparosan-based polysaccharides, including polysaccharides having anticoagulant activity, are also provided.

Claims (22)

1. A method of enzymatically forming an N-,2-O-sulfated heparan sulfate (N,2O-HS) product in the absence of 3′-phosphoadenosine 5′-phosphosulfate (PAPS), the method comprising the following steps:

a. forming a reaction mixture comprising:

i. a sulfo group donor, the sulfo group donor consisting of an aryl sulfate compound;

ii. N-sulfated heparosan; and

iii. a non-natural hexuronyl 2-O sulfotransferase enzyme (2OST), engineered to have sulfotransferase activity with an aryl sulfate compound as a sulfo group donor and N-sulfated heparosan as a sulfo group acceptor;

b. binding the aryl sulfate compound within the enzyme active site; and

c. catalyzing the transfer of the sulfo group from the aryl sulfate compound to N-sulfated heparosan, thereby forming the N,2O-HS product.

2. The method of claim 1 , wherein the amino acid sequence of the non-natural 2OST enzyme is mutated relative to the amino acid sequence of a natural 2OST enzyme within enzyme class EC 2.8.2.-, wherein:

a. the natural 2OST enzyme comprises the following conserved amino acid sequence motifs:

i. a conserved amino acid sequence motif having the amino acid sequence, SEQ ID NO: 244;

ii. a conserved amino acid sequence motif having the amino acid sequence, SEQ ID NO: 245;

iii. a conserved amino acid sequence motif having the amino acid sequence, SEO ID NO: 246;

iv. a conserved amino acid sequence motif having the amino acid sequence, SEQ ID NO: 247, and

b. within the amino acid sequence of the non-natural 2OST enzyme,

i. amino acid sequence SEQ ID NO: 244 is mutated an amino acid sequence selected from the group consisting of SEQ ID NO: 248 and SEQ ID NO: 249; and

ii. amino acid sequence SEQ ID NO: 247 is mutated to SEQ ID NO: 250.

3. The method of claim 2 , wherein within the amino acid sequence of the non-natural 2OST enzyme, the mutated amino acid sequence SEQ ID NO: 248 is selected, and amino acid sequence SEQ ID NO: 245 is mutated to SEQ ID NO: 251.

4. The method of claim 2 , wherein within the amino acid sequence of the non-natural 2OST enzyme, the mutated amino acid sequence SEQ ID NO: 249 is selected, amino acid sequence SEQ ID NO: 245 is mutated to SEQ ID NO: 252, and amino acid sequence SEQ ID NO: 246 is mutated to SEQ ID NO: 253.

5. The method of claim 2 , wherein the non-natural 2OST enzyme comprises an amino acid sequence selected from the group consisting of the amino acid sequences SEQ ID NO: 63, SEQ ID NO: 65, SEQ ID NO: 68, and SEQ ID NO: 69.

6. The method of claim 1 , wherein the aryl sulfate compound is selected from the group consisting of p-nitrophenyl sulfate (PNS) and 4-nitrocatechol sulfate (NCS).

7. The method of claim 1 , wherein the reaction mixture further comprises a glucuronyl C 5 -epimerase.

8. The method of claim 7 , wherein the N,2O-HS product comprises at least one polysaccharide having a C 5 -epimerized hexuronic acid residue and comprising a sequence motif having the structure of Formula VII, below:

Assignments (2)
SECURITY INTEREST Recorded Mar 3, 2023
From: OPTIMVIA, LLC
To: GINKGO BIOWORKS, INC.
Reel/Frame 062873/0616 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2021
From: FERREIRA, TARSIS GESTEIRA
To: OPTIMVIA, LLC
Reel/Frame 056986/0804 →
Continuity (6)
Continuation In Part PCTUS2020013677 · Jan 15, 2020
Provisional Application 62792440 · Jan 15, 2019
Provisional Application 62797466 · Jan 28, 2019
Provisional Application 62808074 · Feb 20, 2019
Provisional Application 62853261 · May 28, 2019
Related Publication 20210363503A1 · Nov 25, 2021